Lifeboat Foundation

We will be returning in 2020 to host our third conference in New York City and brings together the leading experts in aging research and biotech business and investment. Building on the success of our 2018 and 2019 conferences we will continue to bring you the latest research, business, and investment talks from some of the top leaders in their fields.

We will be releasing more information about the conference in the coming months as we confirm speakers, venue, and dates. If you would like to stay informed about developments and ticket offers you may wish to sign up for the conference mailing list below.

Recorded at ApplySci’s Wearable Tech + Digital Health + Neurotech conference — November 14, 2019 | Harvard Medical School.

Liz Parrish in Spanish is still good… AEWR.

Briefing of the highlights of second day (Nov 15, 2019) at the Longevity World Forum that took place in Valencia, Spain.

Continue reading “Briefing of the Longevity World Forum in Valencia, Spain (Nov 2019)” »

We will have a New Presentation on Age Reversal and Cryonics by Bill Faloon. 🤩 😎

Come early and enjoy snacks and conversation and stay afterward as we have a delicious 5-star dinner reception for Bill Faloon.

Before and after the service we will enjoy tasty food and interesting discussions on Age Reversal, Cryonics, Singularity and other topics of interest for all Immortalists.

https://www.youtube.com/watch?v=HOTS0HS7aq4

As part of the LEAF Longevity Bookclub and to celebrate the launch of Dr. David Sinclair’s new book, Lifespan: Why We Age and Why We Don’t Have To, we hosted a special webinar on the 18th of September. The new book takes us on a journey through the biology of why we age and spotlights the exciting research being done in the lab today which could potentially change the way we treat the diseases of aging.

Continue reading “Dr. David Sinclair Webinar – Lifespan: Why We Age – and Why We Don’t Have To” »

Vision Weekend is the annual member gathering of Foresight Institute, a non-profit for advancing beneficial technologies for the long-term flourishing of life.

More info on speakers and program: https://foresight.org/vision-weekend-2019/.
Join Foresight Institute’s community: www.bit.ly/foresightnews

John and Charlotte Henderson, who met at the University of Texas Austin in 1934 and wed five years later, have been recognized by Guinness World Records for the longevity of their love.

Scientists from the Salk Institute for Biological Studies are homing in on exactly how two new experimental Alzheimer’s drugs could be generating the anti-aging effects seen in early animal studies. The discovery of a unique metabolic pathway, associated with both general aging and the onset of dementia, offers researchers novel directions for future anti-aging studies.

Salk researchers have been developing two experimental drugs for several years with a view on improving cognition and slowing the neurodegenerative decline associated with Alzheimer’s disease. Called CMS121 and J147, the drugs were effective in slowing the progression of Alzheimer’s in initial animal tests. However, the compounds also seemed to demonstrate signs of slowing down general markers of brain aging.

As the two drugs move toward human trials, the researchers have been working to uncover exactly what molecular mechanisms are at play to explain how they work. One potential mechanism was uncovered in early 2018 but that was only part of the story. Now, the Salk team has uncovered an exciting new molecular pathway, influenced by the two drugs, that could explain how the compounds slow down brain aging.

Can we live forever?